Search Results

There are 6924 results for: content related to: Antiviral therapy for hepatitis C virus–associated mixed cryoglobulinemia vasculitis: A long-term followup study

  1. You have free access to this content
    Hepatitis C virus: How genetic variability affects pathobiology of disease

    Journal of Gastroenterology and Hepatology

    Volume 26, Issue s1, January 2011, Pages: 83–95, Kazuaki Chayama and C Nelson Hayes

    Article first published online : 4 JAN 2011, DOI: 10.1111/j.1440-1746.2010.06550.x

  2. Peginterferon alfa-2a versus Peginterferon alfa-2b as Initial Treatment of Hepatitis C Virus Infection: A Cost-Utility Analysis from the Perspective of the Veterans Affairs Health Care System

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 27, Issue 6, June 2007, Pages: 813–824, Wei-Shi Yeh, Edward P. Armstrong, Grant H. Skrepnek and Daniel C. Malone

    Article first published online : 6 JAN 2012, DOI: 10.1592/phco.27.6.813

  3. You have free access to this content
    Efficacy and tolerability of rituximab with or without PEGylated interferon alfa-2b plus ribavirin in severe hepatitis C virus–related vasculitis: A long-term followup study of thirty-two patients

    Arthritis & Rheumatism

    Volume 60, Issue 8, August 2009, Pages: 2531–2540, Benjamin Terrier, David Saadoun, Damien Sène, Jérémie Sellam, Laurent Pérard, Brigitte Coppéré, Alexandre Karras, François Blanc, Matthias Buchler, Emmanuelle Plaisier, Pascale Ghillani, Michelle Rosenzwajg and Patrice Cacoub

    Article first published online : 30 JUL 2009, DOI: 10.1002/art.24703

  4. You have free access to this content
    Peginterferon alfa-2a/ribavirin in hepatitis C virus patients nontolerant or nonresponsive to peginterferon alfa-2b/ribavirin

    Alimentary Pharmacology & Therapeutics

    Volume 27, Issue 5, March 2008, Pages: 433–440, V. K. RUSTGI, S. ESPOSITO, F. M. HAMZEH and M. L. SHIFFMAN

    Article first published online : 10 DEC 2007, DOI: 10.1111/j.1365-2036.2007.03587.x

  5. Durability of sustained response shown in paediatric patients with chronic hepatitis C who were treated with interferon alfa-2b plus ribavirin

    Journal of Viral Hepatitis

    Volume 19, Issue 4, April 2012, Pages: 263–270, D. A. Kelly, B. Haber, R. P. González-Peralta, K. F. Murray, M. M. Jonas, J. P. Molleston, M. R. Narkewicz, F. R. Sinatra, T. Lang, A. Lachaux, S. Wirth, M. Shelton, H. S. Te, H. Pollack, W. Deng, S. Noviello and J. K. Albrecht

    Article first published online : 17 NOV 2011, DOI: 10.1111/j.1365-2893.2011.01544.x

  6. You have free access to this content
    A cost-effectiveness analysis of peginterferon alfa-2b plus ribavirin for the treatment of naive patients with chronic hepatitis C

    Alimentary Pharmacology & Therapeutics

    Volume 17, Issue 5, March 2003, Pages: 687–694, M. Buti, M. Medina, M. A. Casado, J. B. Wong, L. Fosbrook and R. Esteban

    Article first published online : 28 FEB 2003, DOI: 10.1046/j.1365-2036.2003.01453.x

  7. You have free access to this content
    Diagnosis, management, and treatment of hepatitis C: An update

    Hepatology

    Volume 49, Issue 4, April 2009, Pages: 1335–1374, Marc G. Ghany, Doris B. Strader, David L. Thomas and Leonard B. Seeff

    Article first published online : 2 DEC 2008, DOI: 10.1002/hep.22759

  8. You have free access to this content
    Abstracts 210 to 431

    Hepatology

    Volume 46, Issue S1, October 2007, Pages: 331A–430A,

    Article first published online : 19 SEP 2007, DOI: 10.1002/hep.22017

  9. You have free access to this content
    Abstracts 1020 to 1278

    Hepatology

    Volume 42, Issue S1, October 2005, Pages: 598A–702A,

    Article first published online : 5 OCT 2005, DOI: 10.1002/hep.20927

  10. Follow-up of Adverse Drug Reactions from Peginterferon alfa-2b—Ribavirin Therapy

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 24, Issue 11, November 2004, Pages: 1546–1553, Dr. Haleh Bagheri, Dr. Atoussa Fouladi, Dr. Karl Barange, Dr. Maryse Lapeyre-Mestre, Dr. Jean-Louis Payen, Dr. Jean Louis Montastruc and Dr. Jean-Pierre Vinel

    Article first published online : 16 JAN 2012, DOI: 10.1592/phco.24.16.1546.50947

  11. You have free access to this content
    Viral kinetics in genotype 1 chronic hepatitis C patients during therapy with 2 different doses of peginterferon alfa-2b plus ribavirin

    Hepatology

    Volume 35, Issue 4, April 2002, Pages: 930–936, Maria Buti, Francisco Sanchez-Avila, Yoav Lurie, Carlos Stalgis, Auristela Valdés, Maria Martell and Rafael Esteban

    Article first published online : 30 DEC 2003, DOI: 10.1053/jhep.2002.32150

  12. You have free access to this content
    PEGylated interferon alfa-2b and ribavirin treatment in patients with hepatitis C virus–related systemic vasculitis

    Arthritis & Rheumatism

    Volume 52, Issue 3, March 2005, Pages: 911–915, Patrice Cacoub, David Saadoun, Nicolas Limal, Damien Sene, Olivier Lidove and Jean-Charles Piette

    Article first published online : 4 MAR 2005, DOI: 10.1002/art.20958

  13. You have free access to this content
    AASLD Abstracts 1143–1352

    Hepatology

    Volume 48, Issue S1, October 2008, Pages: 817A–911A,

    Article first published online : 24 SEP 2008, DOI: 10.1002/hep.22645

  14. Current Therapies for Chronic Hepatitis C

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 31, Issue 1, January 2011, Pages: 92–111, McKenzie C. Ferguson

    Article first published online : 6 JAN 2012, DOI: 10.1592/phco.31.1.92

  15. Early virologic response after peginterferon alpha-2a plus ribavirin or peginterferon alpha-2b plus ribavirin treatment in patients with chronic hepatitis C

    Journal of Viral Hepatitis

    Volume 14, Issue 10, October 2007, Pages: 721–729, A. M. Di Bisceglie, R. H. Ghalib, F. M. Hamzeh and V. K. Rustgi

    Article first published online : 26 APR 2007, DOI: 10.1111/j.1365-2893.2007.00862.x

  16. You have free access to this content
    AASLD Abstract (pp. 162A–266A)

    Hepatology

    Volume 40, Issue S4, October 2004, Pages: 267A–369A,

    Article first published online : 10 FEB 2006, DOI: 10.1002/hep.1840400504

  17. You have free access to this content
    Randomized trial comparing pegylated interferon α-2b versus pegylated interferon α-2a, both plus ribavirin, to treat chronic hepatitis C in human immunodeficiency virus patients

    Hepatology

    Volume 49, Issue 1, January 2009, Pages: 22–31, Montserrat Laguno, Carmen Cifuentes, Javier Murillas, Sergio Veloso, Maria Larrousse, Antoni Payeras, Lucia Bonet, Francese Vidal, Ana Milinkovic, Antoni Bassa, Concha Villalonga, Iñaki Pérez, Cristina Tural, Maria Martínez-Rebollar, Marta Calvo, Jose Luis Blanco, Estaban Martínez, Jose M. Sánchez-Tapias, Jose M. Gatell and Jose Mallolas

    Article first published online : 9 SEP 2008, DOI: 10.1002/hep.22598

  18. Viral Hepatitis

    Textbook of Hepatology: From Basic Science to Clinical Practice, Third Edition

    Mario Rizzetto, Fabien Zoulim, Pages: 819–956, 2008

    Published Online : 15 APR 2008, DOI: 10.1002/9780470691861.ch9a

  19. Estimating the likelihood of sustained virological response in chronic hepatitis C therapy

    Journal of Viral Hepatitis

    Volume 18, Issue 4, April 2011, Pages: e81–e90, S. Mauss, D. Hueppe, C. John, J Goelz, R. Heyne, B. Moeller, R. Link, G. Teuber, A. Herrmann, M. Spelter, S. Wollschlaeger, A. Baumgarten, K.-G. Simon, N. Dikopoulos and T. Witthoeft

    Article first published online : 16 SEP 2010, DOI: 10.1111/j.1365-2893.2010.01372.x

  20. Epoetin alfa for the Treatment of Combination Therapy–Induced Hemolytic Anemia in Patients Infected with Hepatitis C Virus

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 25, Issue 6, June 2005, Pages: 862–875, Dr. Anastasia M. Rivkin and Sweta Chawla

    Article first published online : 16 JAN 2012, DOI: 10.1592/phco.2005.25.6.862